Intrathecal delivery of AAVrh10-mHexa combined with anti-inflammatory treatment reduces neuropathological markers and extends the lifespan of mice with early-onset Tay-Sachs disease. [PDF]
Can M, Ausseil J, Seyrantepe V.
europepmc +1 more source
Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse Models. [PDF]
Kot S +10 more
europepmc +1 more source
Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Efficiently Rescues GM2 Ganglioside Accumulation in Tay-Sachs Disease. [PDF]
Inci OK +6 more
europepmc +1 more source
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay-Sachs Disease. [PDF]
Guerrero-Vargas JM +6 more
europepmc +1 more source
Precise template-free correction restores gene function in Tay-Sachs disease while reframing is ineffective. [PDF]
Hung JE +6 more
europepmc +1 more source
Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series. [PDF]
Fullam S +12 more
europepmc +1 more source
Novel HexA splice site mutations in a patient with late atypical onset Tay-Sachs disease: importance of combined NGS and biochemical analysis. [PDF]
Bilyalova A +8 more
europepmc +1 more source
Infantile Monosialoganglioside2 (GM2) Gangliosidosis With Concurrent Bronchopneumonia: An Extraordinary Case of Tay-Sachs Disease. [PDF]
Grezenko H +5 more
europepmc +1 more source
Whole exome sequencing reveals a homozygous nonsense mutation in HEXA gene leading to Tay-Sachs disease in Saudi Family. [PDF]
Naseer MI +4 more
europepmc +1 more source

